A Comparative Study on the Efficacy and Safety Profile of Intralesional MMR Vaccine And Autoimplantation in The Treatment of Periungual Wart

Authors

  • Rekha Vijayan Author
  • Suresh Mahadevarahalli Rangegowda Author
  • Kodlipet Nirvanappa Vinay Author
  • Banavase ChannakesvaiahRavikumar Author

Keywords:

Warts, Nails, Vaccination

Abstract

Graphical abstract

Background: Warts are benign epidermal tumors of mucocutaneous surface caused by Human Papilloma Virus. They poses 
a therapeutic challenge to the treating dermatologist, particularly periungual warts. The treatment modalities for periungual 
warts are associated with scarring, disfigurement and deformities. Hence immunotherapy has evolved as an effective, safe 
and inexpensive treatment modality.Objectives: To evaluate the efficacy and safety profile of MMR vaccine in the treatment of periungual warts and to compare it with autoimplantation.Methods: In this randomised controlled study on 40 patients with periungual warts, one group (n = 20) were treated with intralesional MMR vaccine and the second group (n = 20)withautoimplantation.Three treatment sessions were carried out in both groups at an interval of two weeks in MMR group and one month in autoimplantation group. Results were assessed by dermatologist’s objective assessment and patient’s subjective score.Results:  Out of 20 recruited patients in MMR group, 18 (90%) showed complete cure and two (10%) had partial clearance. 
In the autoimplantation group, 11 (55%) had complete cure, two had partial clearance and seven (35%) had no response. 
There was statistically significant difference in the response between the two groups during 2nd and 3rd follow up (p value – 0.006 and 0.015) respectively The mean nConclusion: Intralesional MMR vaccine was found to be more effective compared to autoimplantation as far as the duration of treatment, cost, procedural time and feasibility issues are concernedumber of treatment sessions required for complete cure showed no statistically significant difference. 

References

Naseem, R., Aamir, S. (2013) The Efficacy of Intralesional Measles, Mumps, Rubella (MMR) Antigen in Treatment of Common Warts. Pakistan Journal of Medical and Health Sciences, 7(4): 1130-1133.

Gibbs, S., Harvey, I., Sterling, JC., Stark, R. (2003) Local treatments for cutaneous warts. Cochrane Database Syst Rev, 3:CD001781.

Bruggink, SC., Gussekloo, J., Berger, MY., Zaaijer, K., Assendelft, WJ., de Waal, MW., et al. (2010) Cryotherapy with liquid nitrogen versus topical salicylic acid application for cutaneous warts in primary care: randomized controlled trial. CMAJ, 182(15):1624-1630.

Thivolet, J., Viac, J., Staouet, MJ. (1982) Cell-mediated Immunity in Wart Infection. Int J Dermatol, 21(2):94-98.

Signore, RJ. (2002) Candida albicans intralesional injection immunotherapy of warts. Cutis, 70(3):185-192.

Johnson, SM., Roberson, PK., Horn, TD. (2001) Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol, 137(4):451-455.

Johnson, SM., Horn, TD. (2004) Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy. J Drugs Dermatol, 3(3):263- 265.

Clifton, MM., Johnson, SM., Roberson, PK., Kincannon, J., Horn, TD. (2003) Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens. Pediatr dermatol, 20(3):268-271.

Gamil, H., Elgharib, I., Nofal, A., Abd-Elaziz, T. (2010) Intralesional immunotherapy of plantar warts: Report of a new antigen combination. J Am Acad Dermatol, 63(1):40- 43.

Sinha, S., Relhan, V., Garg, VK. (2015) Immunomodulators in warts: Unexplored or ineffective?. Indian journal of dermatology, 60(2):118-129.

Lal, NR., Sil, A., Gayen, T., Bandyopadhyay, D., Das, NK. (2014) Safety and effectiveness of autoinoculation therapy in cutaneous warts: A double-blind, randomized, placebo-controlled study. Indian Journal of Dermatology, Venereology, and Leprology, 80(6):515-520.

Nofal, A., Nofal, E. (2010) Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol, 24(10):1166-1170.

Leman, JA., Benton, EC. (2000) Verrucas. Guidelines for management. Am J Clin Dermatol, 1(3): 143-149.

Signore, RJ. (2002) Candida albicans intralesional injection immunotherapy of warts. Cutis, 70(3):185-192.

Horn, TD., Johnson, SM., Helm, RM., Roberson, PK. (2005) Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol, 141(5): 589-594.

Durgadevi, S., Shridharan, P. (2018) Treatment of periungual warts comparison of topical 5% 5 fluorouracil and intralesional purified protein derivative in a south Indian teaching hospital. Int J Res Dermatol, 4(4): 574-578.

Silverberg, NB., Lim, JK., Paller, AS., Mancini, AJ. (2000) Squaric acid immunotherapy for warts in children. J Am Acad Dermatol, 42(5 Pt 1): 803-808.

Gonclaves, MA., Donadi, EA. (2004) Immune cellular response to HPV Current concepts. Braz J Infect Dis, 8(1): 1-9.

Zamanian, A., Mobasher, P., Jazi, GA. (2014) Efficacy of intralesional injection of mumps measles rubella vaccine in patients with wart. Adv Biomed Res, 3: 107.

Kus, S., Ergun, T., Gun, D., Akin, O. (2005) Intralesional tuberculin for treatment of refractory warts. J Eur Acad Dermatol Venereol, 19(4): 515-516.

Nofal, A., Nofal, E., Yosef, A., Nofal, H. (2015) Treatment of recalcitrant warts with intralesional measles mumps and rubella vaccine a promising approach. Int J Dermatol, 54(6): 667-671.

Na, CH., Choi, H., Song, SH., Kim, MS., Shin, BS. (2014) Two year experience of using the measles mumps and rubella vaccine as intralesional immunotherapy for warts. Clin Exp Dermatol, 39(5): 583-589.

Usman, N., Udayashankar, K., Subramanian, S., Thyagarajan, SP. (1996) Autoimplantation technique in the treatment of anogenital warts a clinico immunological study. Int J STD AIDS, 7(1): 55-57.

Shivakumar, V., Okade, R., Rajkumar, V. (2009) Autoimplantation therapy for multiple warts. Indian J Dermatol Venereol Leprol, 75(6): 593-595.

Srivastava, PK., Bajaj, AK. (2010) Autowart injection therapy for recalcitrant warts. Indian J Dermatol, 55(4): 367- 369.

Nischal, KC., Sowmya, CS., Swaroop, MR., Agrawal, DP., Basavaraj, HB., Sathyanarayana, BD. (2012) A novel modification of the autoimplantation therapy for the treatment of multiple recurrent and palmoplantar warts. J Cutan Aesthet Surg, 5(1): 26-29.

Lal, NR., Sil, A., Gayen, T., Bandyopadhyay, D., Das, NK. (2014) Safety and effectiveness of autoinoculation therapy in cutaneous warts A double blind randomized placebo controlled study. Indian J Dermatol Venereol Leprol, 80(6): 515-520.

EIGhareeb, MI. (2019) Comparative study of autoimplantation and intralesional injection of MMR vaccine in warts treatment. Dermatol Ther, 32(6): e13135.

Shaheen, MA., Salem, SA., Fouad, DA., El Fatah, AA. (2015) Intralesional tuberculin (PPD) versus measles mumps rubella (MMR) vaccine in treatment of multiple warts a comparative clinical and immunological study. Dermatol Ther, 28(4): 194–200.

Graphical abstract

Published

2021-04-19

Issue

Section

Articles